Literature DB >> 31421198

Stealth functionalization of biomaterials and nanoparticles by CD47 mimicry.

Seyed Mohammad Gheibi Hayat1, Vanessa Bianconi2, Matteo Pirro2, Amirhossein Sahebkar3.   

Abstract

Polymeric biomaterials and nanoparticles (NPs) have shown a potential to be widely used for medical purposes. Functional limits of their biocompatibility depend on cellular and molecular responses between host and their artificial surfaces. Accordingly, medical devices of polymer biomaterials like endovascular stents, cardiopulmonary bypass circuits, and prostheses, may trigger inflammation or can be rejected by host due to the induction of immune responses. Furthermore, the main restriction to the use of NPs for medical purposes is their short in vivo circulation time because of their rapid clearance via the reticuloendothelial system. Various methods are under investigation to produce bioinert biomaterials and NPs. Currently, PEGylation and camouflaging are the most common approaches to enhance their biocompatibility. However, the disadvantages and limitations of these methods are leading to research new strategies. The CD47 molecule is well known as a widely expressed cellular surface receptor activating the transudction of the ''don't-eat-me'' signal. This review elaborates on the role of CD47 in the immune system and the application of CD47 mimicry peptides to produce bioinert biomaterials and NPs.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biomimetic nanoparticles; CD47; Membrane-coated nanoparticle; PEGylation; Self-peptide

Mesh:

Substances:

Year:  2019        PMID: 31421198     DOI: 10.1016/j.ijpharm.2019.118628

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  8 in total

1.  Biohybrid Nanosystems for Cancer Treatment: Merging the Best of Two Worlds.

Authors:  Flavia Fontana; Raquél Bartolo; Hélder A Santos
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances.

Authors:  Endong Zhang; Philana Phan; Hanan Ahmed Algarni; Zongmin Zhao
Journal:  Pharm Res       Date:  2022-07-07       Impact factor: 4.200

Review 3.  Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Authors:  Silvia Moreno-Mendieta; Daniel Guillén; Nathaly Vasquez-Martínez; Rogelio Hernández-Pando; Sergio Sánchez; Romina Rodríguez-Sanoja
Journal:  Pharm Res       Date:  2022-06-23       Impact factor: 4.580

4.  EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms.

Authors:  Moon Jung Choi; Kang Chan Choi; Do Hyun Lee; Hwa Yeon Jeong; Seong Jae Kang; Min Woo Kim; In Ho Jeong; Young Myoung You; Jin Suk Lee; Yeon Kyung Lee; Chan Su Im; Yong Serk Park
Journal:  Nanotechnol Sci Appl       Date:  2022-07-05

Review 5.  Role of CD47-SIRPα Checkpoint in Nanomedicine-Based Anti-Cancer Treatment.

Authors:  Haiqin Liao; Chengcheng Niu
Journal:  Front Bioeng Biotechnol       Date:  2022-04-26

Review 6.  Nanoparticles in Endodontics Disinfection: State of the Art.

Authors:  Xavier Roig-Soriano; Eliana B Souto; Firas Elmsmari; Maria Luisa Garcia; Marta Espina; Fernando Duran-Sindreu; Elena Sánchez-López; Jose Antonio González Sánchez
Journal:  Pharmaceutics       Date:  2022-07-21       Impact factor: 6.525

7.  Integrin αvβ6-targeted MR molecular imaging of breast cancer in a xenograft mouse model.

Authors:  Xiaohong Ma; Xinming Zhao; Dengfeng Li; Chengyan Dong
Journal:  Cancer Imaging       Date:  2021-06-29       Impact factor: 3.909

Review 8.  Surface Modification of Bacterial Cellulose for Biomedical Applications.

Authors:  Teresa Aditya; Jean Paul Allain; Camilo Jaramillo; Andrea Mesa Restrepo
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.